HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Recalls Have US FDA Looking At Nutritional Beverage Firms’ Microbial Contamination Controls

Executive Summary

Lyons Magnus recalling 53 nutritional and other beverage products due to potential for microbial contamination, including same type linked to infant formula recall. FDA says reports of potential or confirmed unsafe bacterial levels led it to review its inspection records and industry's practices for preventing contaminations.

You may also be interested in...



US FDA Plans Streamlining Infant Formula Approval Process To Expand Supply Chain

FDA “determined a more streamlined pathway” using information it's received for  products available under enforcement discretion “would help provide for the long-term availability and marketing of many” of those products.

Abbott Among Firms Gaining Formula Import Approvals As Flood Closes Its Michigan Plant

Two days before flooding closed its Sturgis plant, Abbott announced it would import 1.1m pounds of powder formula to the US from its manufacturing facility in Spain.  

DeLauro Whistles For Investigation Of US FDA Response To Whistleblower Report On Abbott Formula Facility

Appropriations chairwoman Rosa DeLauro wants answers from HHS Office of Inspector General about FDA’s response to whistleblower report of contamination at Abbott Nutrition infant formula facility. Report described pattern of unsatisfactory quality control practices at the plant.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS152786

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel